102 related articles for article (PubMed ID: 11222779)
1. Identification of partial loss of function p53 gene mutations utilizing a yeast-based functional assay.
Kovvali GK; Mehta B; Epstein CB; Lutzker SG
Nucleic Acids Res; 2001 Mar; 29(5):E28. PubMed ID: 11222779
[TBL] [Abstract][Full Text] [Related]
2. Novel human p53 mutations that are toxic to yeast can enhance transactivation of specific promoters and reactivate tumor p53 mutants.
Inga A; Resnick MA
Oncogene; 2001 Jun; 20(26):3409-19. PubMed ID: 11423991
[TBL] [Abstract][Full Text] [Related]
3. Mammalian p53 can function as a transcription factor in yeast.
Schärer E; Iggo R
Nucleic Acids Res; 1992 Apr; 20(7):1539-45. PubMed ID: 1579447
[TBL] [Abstract][Full Text] [Related]
4. Oncogenic forms of p53 inhibit p53-regulated gene expression.
Kern SE; Pietenpol JA; Thiagalingam S; Seymour A; Kinzler KW; Vogelstein B
Science; 1992 May; 256(5058):827-30. PubMed ID: 1589764
[TBL] [Abstract][Full Text] [Related]
5. p53 mutants can often transactivate promoters containing a p21 but not Bax or PIG3 responsive elements.
Campomenosi P; Monti P; Aprile A; Abbondandolo A; Frebourg T; Gold B; Crook T; Inga A; Resnick MA; Iggo R; Fronza G
Oncogene; 2001 Jun; 20(27):3573-9. PubMed ID: 11429705
[TBL] [Abstract][Full Text] [Related]
6. p53 mutants exhibiting enhanced transcriptional activation and altered promoter selectivity are revealed using a sensitive, yeast-based functional assay.
Inga A; Monti P; Fronza G; Darden T; Resnick MA
Oncogene; 2001 Jan; 20(4):501-13. PubMed ID: 11313981
[TBL] [Abstract][Full Text] [Related]
7. Human tumor-derived p53 proteins exhibit binding site selectivity and temperature sensitivity for transactivation in a yeast-based assay.
Di Como CJ; Prives C
Oncogene; 1998 May; 16(19):2527-39. PubMed ID: 9627118
[TBL] [Abstract][Full Text] [Related]
8. Differential transactivation by the p53 transcription factor is highly dependent on p53 level and promoter target sequence.
Inga A; Storici F; Darden TA; Resnick MA
Mol Cell Biol; 2002 Dec; 22(24):8612-25. PubMed ID: 12446780
[TBL] [Abstract][Full Text] [Related]
9. Screening patients for heterozygous p53 mutations using a functional assay in yeast.
Ishioka C; Frebourg T; Yan YX; Vidal M; Friend SH; Schmidt S; Iggo R
Nat Genet; 1993 Oct; 5(2):124-9. PubMed ID: 8252037
[TBL] [Abstract][Full Text] [Related]
10. p53 functional loss in a colon cancer cell line with two missense mutations (218leu and 248trp) on separate alleles.
Rand A; Glenn KS; Alvares CP; White MB; Thibodeau SM; Karnes WE
Cancer Lett; 1996 Jan; 98(2):183-91. PubMed ID: 8556707
[TBL] [Abstract][Full Text] [Related]
11. Selection of cell death-deficient p53 mutants in Saccharomyces cerevisiae.
Yacoubi-Hadj Amor I; Smaoui K; Belguith H; Djemal L; Dardouri M; Mokdad-Gargouri R; Gargouri A
Yeast; 2009 Aug; 26(8):441-50. PubMed ID: 19579214
[TBL] [Abstract][Full Text] [Related]
12. Sequence-specific transcriptional activation is essential for growth suppression by p53.
Pietenpol JA; Tokino T; Thiagalingam S; el-Deiry WS; Kinzler KW; Vogelstein B
Proc Natl Acad Sci U S A; 1994 Mar; 91(6):1998-2002. PubMed ID: 8134338
[TBL] [Abstract][Full Text] [Related]
13. Mammalian metal response element-binding transcription factor-1 functions as a zinc sensor in yeast, but not as a sensor of cadmium or oxidative stress.
Daniels PJ; Bittel D; Smirnova IV; Winge DR; Andrews GK
Nucleic Acids Res; 2002 Jul; 30(14):3130-40. PubMed ID: 12136095
[TBL] [Abstract][Full Text] [Related]
14. Understanding the function-structure and function-mutation relationships of p53 tumor suppressor protein by high-resolution missense mutation analysis.
Kato S; Han SY; Liu W; Otsuka K; Shibata H; Kanamaru R; Ishioka C
Proc Natl Acad Sci U S A; 2003 Jul; 100(14):8424-9. PubMed ID: 12826609
[TBL] [Abstract][Full Text] [Related]
15. Transcriptional properties of feline p53 and its tumour-associated mutants: a yeast-based approach.
Cardellino U; Ciribilli Y; Andreotti V; Modesto P; Menichini P; Fronza G; Pellegrino C; Inga A
Mutagenesis; 2007 Nov; 22(6):417-23. PubMed ID: 17947339
[TBL] [Abstract][Full Text] [Related]
16. Use of the two-hybrid system to identify the domain of p53 involved in oligomerization.
Iwabuchi K; Li B; Bartel P; Fields S
Oncogene; 1993 Jun; 8(6):1693-6. PubMed ID: 8502489
[TBL] [Abstract][Full Text] [Related]
17. Novel simplified yeast-based assays of regulators of p53-MDMX interaction and p53 transcriptional activity.
Leão M; Gomes S; Soares J; Bessa C; Maciel C; Ciribilli Y; Pereira C; Inga A; Saraiva L
FEBS J; 2013 Dec; 280(24):6498-507. PubMed ID: 24119020
[TBL] [Abstract][Full Text] [Related]
18. Reporter gene regulation in Saccharomyces cerevisiae by the human p53 tumor suppressor protein.
Bitter GA; Schaeffer TN; Ellison AR
J Mol Microbiol Biotechnol; 2002 Nov; 4(6):539-50. PubMed ID: 12432954
[TBL] [Abstract][Full Text] [Related]
19. A promoter function of the CCCGGG Sma I recognition sequence and its specific role in determining p53 status and identifying DNA damaging agents.
Yang AL; Festing MF
Biochem Biophys Res Commun; 2001 Feb; 281(2):506-10. PubMed ID: 11181076
[TBL] [Abstract][Full Text] [Related]
20. A split-ubiquitin-based assay detects the influence of mutations on the conformational stability of the p53 DNA binding domain in vivo.
Johnsson N
FEBS Lett; 2002 Nov; 531(2):259-64. PubMed ID: 12417323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
